-
2
-
-
75849153398
-
-
Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents [CD ROM]. Vols. I-VIII. International Agency for Research on Cancer (IARC) CancerBase series no. 7. Lyon, France: IARC Press; 2005.
-
Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents [CD ROM]. Vols. I-VIII. International Agency for Research on Cancer (IARC) CancerBase series no. 7. Lyon, France: IARC Press; 2005.
-
-
-
-
3
-
-
0021165732
-
Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer
-
Ahmed T, Sklaroff R, Yagoda A. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol 1984;132:465-8.
-
(1984)
J Urol
, vol.132
, pp. 465-468
-
-
Ahmed, T.1
Sklaroff, R.2
Yagoda, A.3
-
4
-
-
0024494281
-
cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: A Southwest Oncology Group Study
-
Gagliano RG, Blumenstein BA, Crawford ED, Stephens RL, Coltman CA Jr, Costanzi JJ. cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study. J Urol 1989;141:66-7.
-
(1989)
J Urol
, vol.141
, pp. 66-67
-
-
Gagliano, R.G.1
Blumenstein, B.A.2
Crawford, E.D.3
Stephens, R.L.4
Coltman Jr, C.A.5
Costanzi, J.J.6
-
5
-
-
0344378211
-
Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: A phase II study of methotrexate, cisplatin and bleomycin
-
Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol 1998;160:1770-4.
-
(1998)
J Urol
, vol.160
, pp. 1770-1774
-
-
Corral, D.A.1
Sella, A.2
Pettaway, C.A.3
Amato, R.J.4
Jones, D.M.5
Ellerhorst, J.6
-
6
-
-
0032826430
-
Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: A Southwest Oncology Group study
-
Haas GP, Blumenstein BA, Gagliano RG, et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 1999;161:1823-5.
-
(1999)
J Urol
, vol.161
, pp. 1823-1825
-
-
Haas, G.P.1
Blumenstein, B.A.2
Gagliano, R.G.3
-
7
-
-
0026554548
-
Cisplatin and 5-fluorouracil in advanced cancer of the penis
-
Shammas FV, Ous S, Fossa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol 1992;147:630-2.
-
(1992)
J Urol
, vol.147
, pp. 630-632
-
-
Shammas, F.V.1
Ous, S.2
Fossa, S.D.3
-
8
-
-
0032999409
-
-
Wells A. EGF receptor. Int J Biochem Cell Biol 1999;31: 637-43.
-
Wells A. EGF receptor. Int J Biochem Cell Biol 1999;31: 637-43.
-
-
-
-
9
-
-
0026316096
-
Growth factors and cancer
-
Aaronson SA. Growth factors and cancer. Science 1991;254:1146-53.
-
(1991)
Science
, vol.254
, pp. 1146-1153
-
-
Aaronson, S.A.1
-
11
-
-
0034722889
-
The EGF receptor family as targets for cancer therapy
-
Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene 2000;19:6550-65.
-
(2000)
Oncogene
, vol.19
, pp. 6550-6565
-
-
Mendelsohn, J.1
Baselga, J.2
-
12
-
-
22044445517
-
on behalf of the National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer
-
Shepherd FA, Rodrigues Pereira J, Ciuleanu T, et al. on behalf of the National Cancer Institute of Canada Clinical Trials Group. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-32.
-
(2005)
N Engl J Med
, vol.353
, pp. 123-132
-
-
Shepherd, F.A.1
Rodrigues Pereira, J.2
Ciuleanu, T.3
-
13
-
-
0037674062
-
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
-
Cohen EE, Rosen F, Stadler WM, et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003;21:1980-7.
-
(2003)
J Clin Oncol
, vol.21
, pp. 1980-1987
-
-
Cohen, E.E.1
Rosen, F.2
Stadler, W.M.3
-
14
-
-
1842772526
-
Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck
-
Soulieres D, Senzer NN, Vokes EE, Hidalgo M, Agarwala SS, Siu LL. Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck. J Clin Oncol 2004;22:77-85.
-
(2004)
J Clin Oncol
, vol.22
, pp. 77-85
-
-
Soulieres, D.1
Senzer, N.N.2
Vokes, E.E.3
Hidalgo, M.4
Agarwala, S.S.5
Siu, L.L.6
-
15
-
-
34250180582
-
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/ or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy
-
Vermorken JB, Trigo J, Hitt R, et al. Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/ or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy. J Clin Oncol 2007;25:2171-7.
-
(2007)
J Clin Oncol
, vol.25
, pp. 2171-2177
-
-
Vermorken, J.B.1
Trigo, J.2
Hitt, R.3
|